Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Gerard J. O'Dowd"'
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma
Autor:
Edward C. Poole, Manisha Chaudhari, Jüri Palisaar, Gerard J. O'Dowd, Alan W. Partin, Hartwig Huland, Robert W. Veltri, Alexander Haese, Markus Graefen, Peter Hammerer, M. Craig Miller, Jonathan I. Epstein
Publikováno v:
Cancer. 97:969-978
BACKGROUND Quantitative biopsy pathology with prostate specific antigen significantly improves the prediction of pathologic stage in patients with clinically localized prostate carcinoma (PCa). The authors recently reported a computational model for
Publikováno v:
The Journal of Urology. :125-129
Purpose: We assessed the impact of age and prostate specific antigen (PSA) on extended systematic biopsy schemes for detecting prostate carcinoma and better characterized these tumors as a function of patient age and PSA.Materials and Methods: We ret
Autor:
M. Craig Miller, Gerard J. O'Dowd, Edward C. Poole, Manisha Chaudhari, Robert W. Veltri, Alan W. Partin
Publikováno v:
Clinical Chemistry. 48:1828-1834
Background: Prostate cancer (PCa) pathologic staging remains a challenge for the physician using individual pretreatment variables. We have previously reported that UroScoreTM, a logistic regression (LR)-derived algorithm, can correctly predict organ
Publikováno v:
Urology. 57:1105-1111
Objectives. To assess the diagnostic performance of complexed prostate-specific antigen (cPSA), total PSA (tPSA), and calculated free/total PSA (f/t PSA) ratios in the differentiation of benign disease from prostate cancer (CaP) using a contemporary
Publikováno v:
Cancer. 91:2322-2328
BACKGROUND Considerable evidence has shown that the use of computational algorithms to combine pretreatment clinical and pathology results can enhance predictions of patient outcome. The aim of this study was to prove that the application of such met
Publikováno v:
Urology. 52:1064-1069
Objectives. To evaluate the efficacy of applying an age-specific prostate-specific antigen (PSA) reference range to determine whether prostate biopsies are warranted in men 60 to 69 years of age. We estimated the incidence of clinically significant p
Autor:
H. Barton Grossman, Monica Liebert, Joel W. Slaton, M. Craig Miller, Colin P.N. Dinney, Robert W. Veltri, Gerard J. O'Dowd
Publikováno v:
Journal of Urology. 158:806-811
We determined whether deoxyribonucleic acid (DNA) ploidy analysis by image analysis cytometry enhances the cytological diagnosis of recurrent transitional cell carcinoma of the bladder.A retrospective study was performed during a 5-year period to eva
Autor:
Donn C. Young, Robert W. Veltri, Duke K. Bahn, Paul Kochie, Paul A. Peller, Robert A. Badalament, Miller M. Craig, Gerard J. O'Dowd
Publikováno v:
Journal of Urology. 156:1375-1380
Purpose: We determined the enhanced ability to predict nonorgan confined prostate cancer using several histopathological and quantitative nuclear imaging parameters combined with serum prostate specific antigen (PSA).Materials and Methods: Several in
Publikováno v:
Urology. 51:531-533
Objectives. To examine the relationship between positive prostate biopsy rates and age over the range of serum prostate-specific antigen (PSA) concentrations of 4 to 10 ng/mL. Methods. The rates for adenocarcinoma were calculated for prostate biopsy
Publikováno v:
The Journal of urology. 169(1)
We assessed the impact of age and prostate specific antigen (PSA) on extended systematic biopsy schemes for detecting prostate carcinoma and better characterized these tumors as a function of patient age and PSA.We retrospectively reviewed the record